Treatment for Pulmonary Fibrosis in PA

Alternative Treatment for Pulmonary Fibrosis in Pennsylvania

What is Pulmonary Fibrosis?

Pulmonary fibrosis is a disease in which the lungs become scarred, causing the intricate passageways inside the lungs to thicken and harden. Hardening of passageways inside the lungs makes it difficult for oxygen to pass through the walls of the tiny air sacs (alveoli) into the bloodstream. The lack of oxygen in the bloodstream leaves sufferers of pulmonary fibrosis short of breath even after periods of prolonged rest. Pulmonary fibrosis is a progressive disease in which sufferers get worse over time, sometimes slowly and other times rapidly. There are, however, new treatment options that help improve the quality of life for those who suffer from the disease. The Lung Institute offers treatment for pulmonary fibrosis in PA.

Quick Facts about Pulmonary Fibrosis:

  • It affects 200,000 people in the United States.
  • The average survival rate is two to three years.
  • There is no known cause for idiopathic pulmonary fibrosis.
  • About 48,000 new cases are diagnosed each year.
  • The disease tends to affect more men than women and typically occurs between ages 50 to 70
  • Pulmonary fibrosis is caused by occupational and environmental factors, a response from medications, autoimmune disorders, infections and genetics.

Occupational Lung Disease in Pennsylvania

Pennsylvania has several reported cases of occupational lung disease, particularly in Pittsburgh. Pittsburgh is known as the “Steel City” because of the city’s historic past with the steel industry. While this has helped build a strong local economy, unfortunately it also comes with negative health repercussions. In fact, the occupational hazards of working in a steel mill can present just as much as a risk as smoking cigarettes, according to a report released by University of Sheffield’s Department of Medicine. Occupational Lung Disease in Pittsburgh is a real problem, and it’s time that sufferers have alternative options other than the traditional treatment methods.

Lung disease is expensive and many workers have to fight to get employers to cover costs. However, expensive medications, or, in more serious cases, a lung transplant, don’t have to be the only option. Minimally invasive cellular therapy is now an effective treatment for lung disease.

What is Cellular Therapy for Pulmonary Fibrosis?

Cellular therapy harnesses the body’s natural healing capabilities to expedite the healing process. At the Lung Institute, the stem cell procedure is a three day outpatient treatment, where cells are extracted from a person’s blood, fat tissue or bone marrow. After the cells have been extracted, they are treated in a lab on site and then reintroduced into the body directly into the damaged tissue areas. Cells are how your body heals itself after getting a cut or bruise, however, sometimes this healing process can move more slowly than the disease progresses, like in the case of lung disease. By targeting many cells directly onto the damaged tissue, the body has the opportunity to heal itself more quickly. In most cases this results in stopping the progression of the disease or even improved lung function.

The Lung Institute might be the answer for those seeking treatment for pulmonary fibrosis in Pennsylvania. If you or a loved one suffers from a lung disease like COPD, contact one of our patient coordinators today at 888-745-6697 to see if you qualify.


*For more information, go to

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.